Recent Advances in the Development of Multi-Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 13, 2008-11 ,pp. : 1312-1327

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo

By Han Sun-Young  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 518-523

Springer Publishing Company

Access to resources Recommend Favorite

Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer

By Fan Alice C   O'Rourke Jennifer J   Praharaj Dave R   Felsher Dean W  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1495-1509

Informa Healthcare

Access to resources Recommend Favorite

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

By Kataoka Yu  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1352-1360

Springer Publishing Company

Access to resources Recommend Favorite

A Neural Network-Based QSAR Approach for Exploration of Diverse Multi-Tyrosine Kinase Inhibitors and its Comparison with a Fragment-Based Approach

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 4, 2013-12 ,pp. : 482-490

Bentham Science Publishers

Access to resources Recommend Favorite